CrushSCI.com
172平均天数
153中位天数
2最短天数
490最长天数
1412025发文量

Paper Review Records

全部论文审稿周期

20 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

239 天

Risk Factor Profiles May Differ Between Younger‐Onset and Late‐Onset Colorectal Cancer: An Exploratory Analysis of Individual and Cumulative Risk Factors Among the Prostate, Lung, Colorectal and Ovarian Cohort

作者
Lucas Wigston; Muktar Ahmed; Zegeye Abebe; Stephen J. Pandol; Yohannes Adama Melaku; Savio George Barreto展开收起
作者单位
1. Flinders Health and Medical Research Institute, College of Medicine and Public Health Flinders University Adelaide Australia; 2. Division of Digestive and Liver Diseases Cedars‐Sinai Medical Centre Los Angeles California USA; 3. University of California Los Angeles California USA; 4. Division of Surgery and Perioperative Medicine Flinders Medical Centre Adelaide Australia展开收起
PDF源文件 DOI 网页
113 天

Transarterial Chemoembolization and Chemo‐Immunoembolization in Locally Advanced Rectal Cancer: An Updated Systematic Review

作者
Omar Abu Saadeh; Hugo C. Temperley; Niall J. O'Sullivan; Benjamin M. Mac Curtain; Kevin P. Sheahan; Julian Soares; Michael E. Kelly; Satish Warrier; Zi Qin Ng展开收起
作者单位
1. Royal College of Surgeons in Ireland Dublin Ireland; 2. Department of Radiology St. James's Hospital Dublin Ireland; 3. Trinity St James Cancer Institute St James Hospital Dublin 8 Ireland; 4. Northwell Health, New Hyde Park New York New York USA; 5. Department of Urology Lenox Hill Hospital New York New York USA; 6. Department of Radiology Royal Perth Hospital Perth Australia; 7. Department of Surgery Trinity College Dublin University of Dublin Dublin 2 Ireland; 8. School of Medicine Trinity College Dublin Dublin 2 Ireland; 9. Department of Surgery Austin Health Heidelberg Australia; 10. Department of Surgery University of Melbourne Melbourne Australia; 11. International Medical Robotics Academy (IMRA) Melbourne Australia; 12. Department of Surgery Peter MacCallum Cancer Centre Melbourne Australia; 13. Department of Surgery The Alfred Hospital Melbourne Australia; 14. Department of General Surgery Royal Perth Hospital Perth Australia; 15. School of Surgery University of Western Australia Perth Australia展开收起
PDF源文件 DOI 网页
196 天

Real‐World Toxicity and Outcomes of KEYNOTE‐522‐Style Neoadjuvant Pembrolizumab for Triple‐Negative Breast Cancer in Australia

作者
Evon Jude; Sarah Jaboury; Qing Ze Fang; Josephine Stewart; Frances Barnett; Bianca Devitt; Belinda Yeo展开收起
作者单位
1. Austin Health Melbourne Australia; 2. Olivia Newton‐John Cancer Research Institute Melbourne Australia; 3. Western Health Melbourne Australia; 4. Eastern Health Clinical School Monash University Melbourne Australia; 5. Northern Health Melbourne Australia; 6. Eastern Health Melbourne Australia展开收起
PDF源文件 DOI 网页
319 天

Divergent Trends in Head and Neck Cancer Burden in China (1990–2021)

作者
Ming Tang; Kaitai Liu; Zhuo Wu; Yihui Yang; Zhoushu Zheng; Changzeng Zhou; Yongbo Zhang; Xiaoyan Li展开收起
作者单位
1. Department of Otolaryngology Head and Neck Surgery The Affiliated Women and Children's Hospital of Ningbo University Ningbo P. R. China; 2. Department of Radiation Oncology Ningbo Medical Center Lihuili Hospital Ningbo China; 3. Department of Otorhinolaryngology Head and Neck Surgery School of Medicine Shanghai Children's Hospital, Shanghai Jiao Tong University Shanghai China展开收起
PDF源文件 DOI 网页
153 天

Cancer of Unknown Primary in Transition: From Empirical Chemotherapy to Immunotherapy and Molecularly Guided Treatment

作者
Tamotsu Sagawa; Masahiro Hirakawa; Hiroyuki Nagashima; Koshi Fujikawa展开收起
作者单位
1. Department of Gastroenterology National Hospital Organization Hokkaido Cancer Center Sapporo Japan; 2. Division of Medical Oncology Department of Internal Medicine Sapporo Medical University School of Medicine Sapporo Japan展开收起
PDF源文件 DOI 网页
24 天

Re: “Impact of RAS/RAF Mutations on Metastatic Treatment Response Following Total Neoadjuvant Therapy in Patients With Stage IV Rectal Cancer.”

作者
Gharbi Lassad展开收起
作者单位
1. Mongi Slim Hospital Tunis Tunisia; 2. University Medicine Tunis Tunis Tunisia展开收起
PDF源文件 DOI 网页

FAQ

Asia-Pacific Journal of Clinical Oncology审稿要多久?

截至2026-11-17,CrushSCI 收录了 Asia-Pacific Journal of Clinical Oncology 的 20 篇完整审稿记录。最快一篇从收稿到录用用了 2 天(Response Letter: Re: “Impact of RAS/RAF Mutations on Metastatic Treatment Response Following Total Neoadjuvant Therapy in Patients With Stage IV Rectal Cancer”,2026-10-12 收稿,2026-10-14 录用),最慢一篇用了 490 天;平均 172 天,中位数 153 天。最快这篇的日期间隔异常短,建议点开原文核对。

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。